"Adaptive Immunity" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Protection from an infectious disease agent that is mediated by B- and T- LYMPHOCYTES following exposure to specific antigen, and characterized by IMMUNOLOGIC MEMORY. It can result from either previous infection with that agent or vaccination (IMMUNITY, ACTIVE), or transfer of antibody or lymphocytes from an immune donor (IMMUNIZATION, PASSIVE).
| Descriptor ID |
D056704
|
| MeSH Number(s) |
G12.450.050
|
| Concept/Terms |
Adaptive Immunity- Adaptive Immunity
- Adoptive Immunity
- Immunity, Adoptive
- Immunity, Adaptive
- Acquired Immunity
- Immunity, Acquired
|
Below are MeSH descriptors whose meaning is more general than "Adaptive Immunity".
Below are MeSH descriptors whose meaning is more specific than "Adaptive Immunity".
This graph shows the total number of publications written about "Adaptive Immunity" by people in this website by year, and whether "Adaptive Immunity" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2010 | 2 | 3 | 5 |
| 2011 | 1 | 2 | 3 |
| 2012 | 1 | 4 | 5 |
| 2013 | 0 | 1 | 1 |
| 2014 | 1 | 1 | 2 |
| 2015 | 6 | 1 | 7 |
| 2016 | 4 | 4 | 8 |
| 2017 | 2 | 4 | 6 |
| 2018 | 2 | 0 | 2 |
| 2019 | 4 | 7 | 11 |
| 2020 | 0 | 2 | 2 |
| 2021 | 2 | 4 | 6 |
| 2022 | 0 | 1 | 1 |
| 2023 | 0 | 1 | 1 |
| 2024 | 1 | 1 | 2 |
| 2025 | 1 | 1 | 2 |
| 2026 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Adaptive Immunity" by people in Profiles.
-
Anti-CSF-1R therapy with combined immuno-chemotherapy coordinate an adaptive immune response to eliminate macrophage enriched triple negative breast cancers. Nat Commun. 2026 Jan 03; 17(1):1193.
-
The zebrafish as a potential model for vaccine and adjuvant development. Expert Rev Vaccines. 2024 Jan-Dec; 23(1):535-545.
-
Spliceosome-targeted therapies trigger an antiviral immune response in triple-negative breast cancer. Cell. 2021 01 21; 184(2):384-403.e21.
-
Critical role of integrin CD11c in splenic dendritic cell capture of missing-self CD47 cells to induce adaptive immunity. Proc Natl Acad Sci U S A. 2018 06 26; 115(26):6786-6791.
-
Metabolic Phenotypes of Response to Vaccination in Humans. Cell. 2017 May 18; 169(5):862-877.e17.
-
Cross-Regulation of Two Type I Interferon Signaling Pathways in Plasmacytoid Dendritic Cells Controls Anti-malaria Immunity and Host Mortality. Immunity. 2016 11 15; 45(5):1093-1107.
-
Adaptive immunity programmes in breast cancer. Immunology. 2017 Jan; 150(1):25-34.
-
Stepping Out of the Cytosol: AIMp1/p43 Potentiates the Link Between Innate and Adaptive Immunity. Int Rev Immunol. 2015; 34(5):367-81.
-
"Let there be light": the role of vitamin D in the immune response to vaccines. Expert Rev Vaccines. 2015; 14(11):1427-40.
-
Delta-24-RGD oncolytic adenovirus elicits anti-glioma immunity in an immunocompetent mouse model. PLoS One. 2014; 9(5):e97407.